DMSO regulates osteoclast development in vitro

In Vitro Cellular and Developmental Biology - Animal

Volumn 47, Issue 3, 2011, Pages 260-267

  Lemieux, Justin M ^a   Wu, Gary ^b   Morgan, Joseph A ^b   Kacena, Melissa A ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

Differentiation; Dimethyl sulfoxide; Maturation; Osteoclast

Indexed keywords

DIMETHYL SULFOXIDE;

ANIMAL; ARTICLE; CELL COUNT; CYTOLOGY; DRUG EFFECT; MOUSE; OSTEOCLAST; SURFACE PROPERTY; TIME;

ANIMALS; CELL COUNT; DIMETHYL SULFOXIDE; MICE; OSTEOCLASTS; SURFACE PROPERTIES; TIME FACTORS;

EID: 79956116528     PISSN: 10712690     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11626-011-9385-8     Document Type: Article

References (49)

1. Aoki K.; Saito H.; Itzstein C.; Ishiguro M.; Shibata T.; Blanque R.; Mian A. H.; Takahashi M.; Suzuki Y.; Yoshimatsu M.; Yamaguchi A.; Deprez P.; Mollat P.; Murali R.; Ohya K.; Horne W. C.; Baron R. A TNF receptor loop peptide mimic blocks RANK ligand-induced signaling, bone resorption, and bone loss. J Clin Invest 116:1525-1534;2006.
2. Archer J. M.; Shilkin K. B.; Papadimitriou J. M.; Walters M. N. Interaction of dimethylsulfoxide and ascorbic acid on fibroblasts of rats. Proc Soc Exp Biol Med 126:354-356; 1967.
3. Ashkenazi A.; Dixit V. M. Death receptors: signaling and modulation. Science 281:1305-1308;1998. (Pubitemid 28406815)
4. Brennan J. K.; Lee K. S.; Frazel M. A.; Keng P. C.; Young D. A. Interactions of dimethyl sulfoxide and granulocyte-macrophage colony-stimulating factor on the cell cycle kinetics and phosphoproteins of G1-enriched HL-60 cells: evidence of early effects on lamin B phosphorylation. J Cell Physiol 146:425-434; 1991. (Pubitemid 21910068)
5. Chang E. J.; Ha J.; Huang H.; Kim H. J.; Woo J. H.; Lee Y.; Lee Z. H.; Kim J. H.; Kim H. H. The JNK-dependent CaMK pathway restrains the reversion of committed cells during osteoclast differentiation. J Cell Sci 121:2555-2564;2008.
6. Collins S. J.; Bodner A.; Ting R.; Gallo R. C. Induction of morphological and functional differentiation of human promyelocytic leukemia cells (HL-60) by componuds which induce differentiation of murine leukemia cells. Int J Cancer 25:213-218; 1980. (Pubitemid 10217394)
7. Collins S. J.; Ruscetti F. W.; Gallagher R. E.; Gallo R. C. Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds. Proc Natl Acad Sci U S A 75:2458-2462;1978. (Pubitemid 8346181)
8. David M. D.; Cochrane C. L.; Duncan S. K.; Schrader J. W. Pure lipopolysaccharide or synthetic lipid A induces activation of p21Ras in primary macrophages through a pathway dependent on Src family kinases and PI3K. J Immunol 175:8236-8241;2005. (Pubitemid 41798388)
9. de Vries T. J.; Mullender M. G.; van Duin M. A.; Semeins C. M.; James N.; Green T. P.; Everts V.; Klein-Nulend J. The Src inhibitor AZD0530 reversibly inhibits the formation and activity of human osteoclasts. Mol Cancer Res 7:476-488; 2009.
10. Depraetere S.; Vanhaesebroeck B.; Fiers W.; Willems J.; Joniau M. Polar agents with differentiation inducing capacity potentiate tumor necrosis factor-mediated cytotoxicity in human myeloid cell lines. J Leukoc Biol 57:141-151; 1995.
11. Egli R. J.; Sckell A.; Fraitzl C. R.; Felix R.; Ganz R.; Hofstetter W.; Leunig M. Cryopreservation with dimethyl sulfoxide sustains partially the biological function of osteochondral tissue. Bone 33:352-361; 2003. (Pubitemid 37103252)
12. Fowler A. V.; Camien M. N.; Dunn M. S. Acetyl L-isoleucine and acetyl L-leucine as extracellular products of Mycobacterium ranae. J Bacteriol 81:163-164; 1961.
13. Franz T. J.; Van Bruggen J. T. A possible mechanism of action of DMSO. Ann N y Acad Sci 141:302-309; 1967.
14. Friend C.; Freedman H. A. Effects and possible mechanism of action of dimethylsulfoxide on Friend cell differentiation. Biochem Pharmacol 27:1309-1313;1978. (Pubitemid 8401715)
15. Hassan H. T. Differentiation inducers of human myeloid leukaemia cell lines. Folia Haematol Int Mag Klin Morphol Blutforsch 115:887-896; 1988. (Pubitemid 19032210)
16. Hayashi S.; Yamada T.; Tsuneto M.; Yamane T.; Takahashi M.; Shultz L. D.; Yamazaki H. Distinct osteoclast precursors in the bone marrow and extramedullary organs characterized by responsiveness to Toll-like receptor ligands and TNF-alpha. J Immunol 171:5130-5139;2003. (Pubitemid 37432796)
17. Hervas J. P.; Gimenez-Martin G. Dimethyl sulphoxide effect on division cells. Experientia 29:1540-1542;1973.
18. Horowitz M. C.; Xi Y.; Pflugh D. L.; Hesslein D. G.; Schatz D. G.; Lorenzo J. A.; Bothwell A. L. Pax5-deficient mice exhibit early onset osteopenia with increased osteoclast progenitors. J Immunol 173:6583-6591;2004. (Pubitemid 39541041)
19. Jacob S. W.; Bischel M.; Herschler R. J. Dimethyl sulfoxide: effects on the permeability of biologic membranes (Preliminary report). Curr Ther Res Clin Exp 6:193-198; 1964.
20. Kacena M. A.; Nelson T.; Clough M. E.; Lee S. K.; Lorenzo J. A.; Gundberg C. M.; Horowitz M. C. Megakaryocyte-mediated inhibition of osteoclast development. Bone 39:991-999; 2006. (Pubitemid 44528382)
21. Keil H. L. Accumulation and persistence of sulfur-35 in peach foliage and fruit sprayed with radiolabeled dimethyl sulfoxide. Ann N y Acad Sci 243:237; 1975.
22. Kelly K. A.; Hill M. R.; Youkhana K.; Wanker F.; Gimble J. M. Dimethyl sulfoxide modulates NF-kappa B and cytokine activation in lipopolysaccharide- treated murine macrophages. Infect Immun 62:3122-3128;1994. (Pubitemid 24232091)
23. Kitajima K.; Haque M.; Nakamura H.; Hirano T.; Utiyama H. Loss of irreversibility of granulocytic differentiation induced by dimethyl sulfoxide in HL-60 sublines with a homogeneously staining region. Biochem Biophys Res Commun 288:1182-1187;2001. (Pubitemid 33131725)
24. Kligman A. M. Dimethyl sulfoxide. 2. JAMA 193:923-928; 1965a. CONCL.
25. Kligman A. M. Topical pharmacology and toxicology of dimethyl sulfoxide. 1. JAMA 193:796-804; 1965b.
26. Komarova S. V.; Shum J. B.; Paige L. A.; Sims S. M.; Dixon S. J. Regulation of osteoclasts by calcitonin and amphiphilic calcitonin conjugates: role of cytosolic calcium. Calcif Tissue Int 73:265-273; 2003. (Pubitemid 37152888)
27. Lyman G. H.; Preisler H. D.; Papahadjopoulos D. Membrane action of DMSO and other chemical inducers of Friend leukaemic cell differentiation. Nature 262:361-363; 1976.
28. MacGregor W. S. The chemical and physical properties of DMSO. Ann N y Acad Sci 141:3-12; 1967.
29. Marthyn P.; Beuscart A.; Coll J.; Moreau-Gachelin F.; Righi M. DMSO reduces CSF-1 receptor levels and causes apoptosis in vmyc immortalized mouse macrophages. Exp Cell Res 243:94-100; 1998. (Pubitemid 28397638)
30. Myers R. F.; Siegel M. I. The appearance of phospholipase activity in the human macrophage-like cell line U937 during dimethyl sulfoxide induced differentiation. Biochem Biophys Res Commun 118:217-224; 1984. (Pubitemid 14191964)
31. Nakamura T.; Kharbanda S.; Spriggs D.; Kufe D. Effects of dexamethasone on induction of monocytic differentiation in human U-937 cells by dimethylsulfoxide. J Cell Physiol 142:261-267; 1990.
32. Narula P. N. The comparative penetrant-carrier action of dimethyl sulfoxide and ethyl alcohol in vivo. Ann N y Acad Sci 141:277-278; 1967.
33. Ohashi M.; Iwase M.; Nagumo M. Changes in susceptibility to Fasmediated apoptosis during differentiation of HL-60 cells. J Leukoc Biol 67:374-380; 2000.
34. Ohno H.; Kubo K.; Murooka H.; Kobayashi Y.; Nishitoba T.; Shibuya M.; Yoneda T.; Isoe T. A c-fms tyrosine kinase inhibitor, Ki20227, suppresses osteoclast differentiation and osteolytic bone destruction in a bone metastasis model. Mol Cancer Ther 5:2634-2643;2006. (Pubitemid 44848990)
35. Park H.; Jung Y. K.; Park O. J.; Lee Y. J.; Choi J. Y.; Choi Y. Interaction of Fas ligand and Fas expressed on osteoclast precursors increases osteoclastogenesis. J Immunol 175:7193-7201;2005. (Pubitemid 41713413)
36. Preisler H. D.; Lyman G. Differentiation of erythroleukemia cells in vitro: properties of chemical inducers, vol 4. North-Holland Publishing Company, Amsterdam, pp 179-185; 1975.
37. Rammler D. H. The effect of DMSO on several enzyme systems. Ann N y Acad Sci 141:291-299; 1967.
38. Rammler D. H.; Zaffaroni A. Biological implications of DMSO based on a review of its chemical properties. Ann N y Acad Sci 141:13-23; 1967.
39. Rawadi G.; Vayssiere B.; Dunn F.; Baron R.; Roman-Roman S. BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop. J Bone Miner Res 18:1842-1853;2003. (Pubitemid 37322562)
40. Saito H.; Kojima T.; Takahashi M.; Horne W. C.; Baron R.; Amagasa T.; Ohya K.; Aoki K. A tumor necrosis factor receptor loop peptide mimic inhibits bone destruction to the same extent as anti-tumor necrosis factor monoclonal antibody in murine collagen-induced arthritis. Arthritis Rheum 56:1164-1174;2007. (Pubitemid 46608641)
41. Sams Jr. W. M.; Carroll N. V. Cholinesterase inhibitory property of dimethyl sulphoxide. Nature 212:405; 1966.
42. Santos N. C.; Figueira-Coelho J.; Martins-Silva J.; Saldanha C. Multidisciplinary utilization of dimethyl sulfoxide: pharmacological, cellular, and molecular aspects. Biochem Pharmacol 65:1035-1041;2003. (Pubitemid 36349743)
43. Stoughton R. B.; Fritsch W. Influence of dimethylsulfoxide (DMSO) on human percutaneous absorption. Arch Dermatol 90:512-517; 1964.
44. Takase K.; Sawai M.; Yamamoto K.; Yata J.; Takasaki Y.; Teraoka H.; Tsukada K. Reversible G1 arrest induced by dimethyl sulfoxide in human lymphoid cell lines: kinetics of the arrest and expression of the cell cycle marker proliferating cell nuclear antigen in Raji cells. Cell Growth Differ 3:515-521; 1992.
45. Udagawa N.; Takahashi N.; Akatsu T.; Sasaki T.; Yamaguchi A.; Kodama H.; Martin T. J.; Suda T. The bone marrow-derived stromal cell lines MC3T3-G2/PA6 and ST2 support osteoclastlike cell differentiation in cocultures with mouse spleen cells. Endocrinology 125:1805-1813;1989. (Pubitemid 19258613)
46. Vondracek J.; Sheard M. A.; Krejci P.; Minksova K.; Hofmanova J.; Kozubik A. Modulation of death receptor-mediated apoptosis in differentiating human myeloid leukemia HL-60 cells. J Leukoc Biol 69:794-802; 2001. (Pubitemid 32466419)
47. Vondracek J.; Soucek K.; Sheard M. A.; Chramostova K.; Andrysik Z.; Hofmanova J.; Kozubik A. Dimethyl sulfoxide potentiates death receptor-mediated apoptosis in the human myeloid leukemia U937 cell line through enhancement of mitochondrial membrane depolarization. Leuk Res 30:81-89; 2006. (Pubitemid 41654709)
48. Yasuda H.; Shima N.; Nakagawa N.; Mochizuki S. I.; Yano K.; Fujise N.; Sato Y.; Goto M.; Yamaguchi K.; Kuriyama M.; Kanno T.; Murakami A.; Tsuda E.; Morinaga T.; Higashio K. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology 139:1329-1337;1998. (Pubitemid 28510154)
49. Zhou P.; Kitaura H.; Teitelbaum S. L.; Krystal G.; Ross F. P.; Takeshita S. SHIP1 negatively regulates proliferation of osteoclast precursors via Akt-dependent alterations in D-type cyclins and p27. J Immunol 177:8777-8784;2006. (Pubitemid 44893844)